<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Deposition of beta-amyloid in the brains of patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> is thought to precede a chain of events that leads to an <z:mp ids='MP_0001845'>inflammatory response</z:mp> by the brain </plain></SENT>
<SENT sid="1" pm="."><plain>We postulated that genetic variation in the regulatory region of the gene for the proinflammatory cytokine <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNF-alpha) leads to increased risk of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A polymorphism in the regulatory region of the TNF-alpha gene was analysed in a case-control study </plain></SENT>
<SENT sid="3" pm="."><plain>The polymorphism (C-850T) was typed in 242 patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, 81 patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, 61 <z:hpo ids='HP_0001297'>stroke</z:hpo> patients without <z:hpo ids='HP_0000726'>dementia</z:hpo>, and 235 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="4" pm="."><plain>These groups of individuals were also genotyped for the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E polymorphism, and the vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> groups were typed at the HLA-DR locus </plain></SENT>
<SENT sid="5" pm="."><plain>FINDINGS: The distribution of TNF-alpha genotypes in the vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> group differed significantly from that in the <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:mpath ids='MPATH_458'>normal</z:mpath> control groups, giving an odds ratio of 2.51 (95% CI 1.49-4.21) for the development of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> for individuals with a CT or TT genotype </plain></SENT>
<SENT sid="6" pm="."><plain>Logistic regression analysis indicated that the possession of the T allele significantly increased the risk of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> associated with carriage of the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E epsilon4 allele (odds ratio 2.73 [1.68-4.44] for those with <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E epsilon4 but no TNF-<z:chebi fb="0" ids="36015">alpha T</z:chebi>, vs 4.62 [2.38-8.96] for those with <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E epsilon4 and TNF-<z:chebi fb="0" ids="36015">alpha T</z:chebi>; p=0.03) </plain></SENT>
<SENT sid="7" pm="."><plain>INTERPRETATION: Possession of the TNF-<z:chebi fb="0" ids="36015">alpha T</z:chebi> allele significantly increases the risk of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, and increases the risk of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> associated with <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E </plain></SENT>
<SENT sid="8" pm="."><plain>Although further research is needed, these findings suggest a potential role for anti-inflammatory therapy in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, and perhaps especially in patients who have had a <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>